|
2024-09-17 |
2024-09-13 |
S
Sale
|
Elsbree David B
Non-Executive Director
|
55
-70.5%
2.42
USD 133
|
55
-70.5%
|
2.42
|
USD 133
|
|
|
2023-09-29 |
2023-09-28 |
S
Sale
|
CR Group L.P.
Large shareholder
|
1,937,852
-100.0%
0.16
USD 305,212
|
1,937,852
-100.0%
|
0.16
|
USD 305,212
|
|
|
2023-09-29 |
2023-09-28 |
S
Sale
|
CR Group L.P.
Large shareholder
|
571,796
-100.0%
0.16
USD 90,058
|
571,796
-100.0%
|
0.16
|
USD 90,058
|
|
|
2023-09-29 |
2023-09-28 |
S
Sale
|
CR Group L.P.
Large shareholder
|
1,780,317
-100.0%
0.16
USD 280,400
|
1,780,317
-100.0%
|
0.16
|
USD 280,400
|
|
|
2023-09-29 |
2023-09-28 |
S
Sale
|
CR Group L.P.
Large shareholder
|
2,858,980
-100.0%
0.16
USD 450,289
|
2,858,980
-100.0%
|
0.16
|
USD 450,289
|
|
|
2023-09-29 |
2023-09-27 |
S
Sale
|
CR Group L.P.
Large shareholder
|
1,621,313
-45.6%
0.19
USD 310,644
|
1,621,313
-45.6%
|
0.19
|
USD 310,644
|
|
|
2023-09-29 |
2023-09-27 |
S
Sale
|
CR Group L.P.
Large shareholder
|
478,396
-45.6%
0.19
USD 91,661
|
478,396
-45.6%
|
0.19
|
USD 91,661
|
|
|
2023-09-29 |
2023-09-27 |
S
Sale
|
CR Group L.P.
Large shareholder
|
1,489,512
-45.6%
0.19
USD 285,390
|
1,489,512
-45.6%
|
0.19
|
USD 285,390
|
|
|
2023-09-29 |
2023-09-27 |
S
Sale
|
CR Group L.P.
Large shareholder
|
2,391,981
-45.6%
0.19
USD 458,304
|
2,391,981
-45.6%
|
0.19
|
USD 458,304
|
|
|
2023-09-28 |
2023-09-26 |
S
Sale
|
CR Group L.P.
Large shareholder
|
1,461,849
-29.1%
0.20
USD 293,393
|
1,461,849
-29.1%
|
0.20
|
USD 293,393
|
|
|
2023-09-28 |
2023-09-26 |
S
Sale
|
CR Group L.P.
Large shareholder
|
431,343
-29.1%
0.20
USD 86,571
|
431,343
-29.1%
|
0.20
|
USD 86,571
|
|
|
2023-09-28 |
2023-09-26 |
S
Sale
|
CR Group L.P.
Large shareholder
|
1,343,011
-29.1%
0.20
USD 269,542
|
1,343,011
-29.1%
|
0.20
|
USD 269,542
|
|
|
2023-09-28 |
2023-09-26 |
S
Sale
|
CR Group L.P.
Large shareholder
|
2,156,717
-29.1%
0.20
USD 432,853
|
2,156,717
-29.1%
|
0.20
|
USD 432,853
|
|
|
2023-09-27 |
2023-09-25 |
S
Sale
|
CR Group L.P.
Large shareholder
|
67,767
-1.3%
0.25
USD 16,942
|
67,767
-1.3%
|
0.25
|
USD 16,942
|
|
|
2023-09-27 |
2023-09-25 |
S
Sale
|
CR Group L.P.
Large shareholder
|
19,996
-1.3%
0.25
USD 4,999
|
19,996
-1.3%
|
0.25
|
USD 4,999
|
|
|
2023-09-27 |
2023-09-25 |
S
Sale
|
CR Group L.P.
Large shareholder
|
62,258
-1.3%
0.25
USD 15,565
|
62,258
-1.3%
|
0.25
|
USD 15,565
|
|
|
2023-09-27 |
2023-09-25 |
S
Sale
|
CR Group L.P.
Large shareholder
|
99,979
-1.3%
0.25
USD 24,995
|
99,979
-1.3%
|
0.25
|
USD 24,995
|
|
|
2023-09-26 |
2023-09-22 |
S
Sale
|
CR Group L.P.
Large shareholder
|
1,376,848
-21.3%
0.26
USD 356,328
|
1,376,848
-21.3%
|
0.26
|
USD 356,328
|
|
|
2023-09-26 |
2023-09-22 |
S
Sale
|
CR Group L.P.
Large shareholder
|
406,263
-21.3%
0.26
USD 105,141
|
406,263
-21.3%
|
0.26
|
USD 105,141
|
|
|
2023-09-26 |
2023-09-22 |
S
Sale
|
CR Group L.P.
Large shareholder
|
1,264,920
-21.3%
0.26
USD 327,361
|
1,264,920
-21.3%
|
0.26
|
USD 327,361
|
|
|
2023-09-26 |
2023-09-22 |
S
Sale
|
CR Group L.P.
Large shareholder
|
2,031,313
-21.3%
0.26
USD 525,704
|
2,031,313
-21.3%
|
0.26
|
USD 525,704
|
|
|
2023-09-25 |
2023-09-21 |
S
Sale
|
CR Group L.P.
Large shareholder
|
1,718,087
-21.0%
0.30
USD 516,285
|
1,718,087
-21.0%
|
0.30
|
USD 516,285
|
|
|
2023-09-25 |
2023-09-21 |
S
Sale
|
CR Group L.P.
Large shareholder
|
506,951
-21.0%
0.30
USD 152,339
|
506,951
-21.0%
|
0.30
|
USD 152,339
|
|
|
2023-09-25 |
2023-09-21 |
S
Sale
|
CR Group L.P.
Large shareholder
|
1,578,419
-21.0%
0.30
USD 474,315
|
1,578,419
-21.0%
|
0.30
|
USD 474,315
|
|
|
2023-09-25 |
2023-09-21 |
S
Sale
|
CR Group L.P.
Large shareholder
|
2,534,754
-21.0%
0.30
USD 761,694
|
2,534,754
-21.0%
|
0.30
|
USD 761,694
|
|
|
2023-09-22 |
2023-09-20 |
S
Sale
|
CR Group L.P.
Large shareholder
|
2,101,784
-20.4%
0.31
USD 652,814
|
2,101,784
-20.4%
|
0.31
|
USD 652,814
|
|
|
2023-09-22 |
2023-09-20 |
S
Sale
|
CR Group L.P.
Large shareholder
|
620,167
-20.4%
0.31
USD 192,624
|
620,167
-20.4%
|
0.31
|
USD 192,624
|
|
|
2023-09-22 |
2023-09-20 |
S
Sale
|
CR Group L.P.
Large shareholder
|
1,930,923
-20.4%
0.31
USD 599,745
|
1,930,923
-20.4%
|
0.31
|
USD 599,745
|
|
|
2023-09-22 |
2023-09-20 |
S
Sale
|
CR Group L.P.
Large shareholder
|
3,100,836
-20.4%
0.31
USD 963,120
|
3,100,836
-20.4%
|
0.31
|
USD 963,120
|
|
|
2023-09-21 |
2023-09-19 |
S
Sale
|
CR Group L.P.
Large shareholder
|
2,819,506
-21.5%
0.37
USD 1,031,939
|
2,819,506
-21.5%
|
0.37
|
USD 1,031,939
|
|
|
2023-09-21 |
2023-09-19 |
S
Sale
|
CR Group L.P.
Large shareholder
|
831,943
-21.5%
0.37
USD 304,491
|
831,943
-21.5%
|
0.37
|
USD 304,491
|
|
|
2023-09-21 |
2023-09-19 |
S
Sale
|
CR Group L.P.
Large shareholder
|
2,590,300
-21.5%
0.37
USD 948,050
|
2,590,300
-21.5%
|
0.37
|
USD 948,050
|
|
|
2023-09-21 |
2023-09-19 |
S
Sale
|
CR Group L.P.
Large shareholder
|
4,159,717
-21.5%
0.37
USD 1,522,456
|
4,159,717
-21.5%
|
0.37
|
USD 1,522,456
|
|
|
2023-04-06 |
2023-03-28 |
PS
Planned sale
|
Gibbs Michael Terrence
General Counsel
Officer
|
239
-3.5%
0.48
USD 115
|
239
-3.5%
|
0.48
|
USD 115
|
|
|
2023-03-09 |
2023-02-28 |
PS
Planned sale
|
Gibbs Michael Terrence
General Counsel
Officer
|
1,585
-19.6%
0.59
USD 935
|
1,585
-19.6%
|
0.59
|
USD 935
|
|
|
2023-03-09 |
2023-02-28 |
PS
Planned sale
|
Sperzel John J III
Chairman and CEO
Executive Director
|
2,898
-14.3%
0.59
USD 1,710
|
2,898
-14.3%
|
0.59
|
USD 1,710
|
|
|
2023-03-09 |
2023-02-28 |
PS
Planned sale
|
Sprague John M
Chief Financial Officer
Officer
|
1,148
-13.6%
0.59
USD 677
|
1,148
-13.6%
|
0.59
|
USD 677
|
|
|
2023-03-09 |
2023-02-22 |
PS
Planned sale
|
Gibbs Michael Terrence
General Counsel
Officer
|
2,145
-29.3%
0.65
USD 1,394
|
2,145
-29.3%
|
0.65
|
USD 1,394
|
|
|
2023-03-09 |
2023-02-22 |
PS
Planned sale
|
Sperzel John J III
Chairman and CEO
Executive Director
|
6,875
-33.6%
0.65
USD 4,469
|
6,875
-33.6%
|
0.65
|
USD 4,469
|
|
|
2023-03-09 |
2023-02-22 |
PS
Planned sale
|
Giffin Brett A.
Chief Commercial Officer
Officer
|
537
-39.0%
0.65
USD 349
|
537
-39.0%
|
0.65
|
USD 349
|
|
|
2023-03-09 |
2023-02-22 |
PS
Planned sale
|
Sprague John M
Chief Financial Officer
Officer
|
1,545
-21.9%
0.65
USD 1,004
|
1,545
-21.9%
|
0.65
|
USD 1,004
|
|
|
2022-11-22 |
2022-11-10 |
S
Sale
|
Giffin Brett A.
Chief Commercial Officer
Officer
|
1,292
-36.4%
1.79
USD 2,317
|
1,292
-36.4%
|
1.79
|
USD 2,317
|
|
|
2022-04-11 |
2022-04-08 |
B
Purchase
|
Barclay Alec
Chief Operations Officer
Officer
|
12,952
+7.7%
0.50
USD 6,476
|
12,952
+7.7%
|
0.50
|
USD 6,476
|
|
|
2022-04-11 |
2022-04-08 |
B
Purchase
|
Sprague John M
Chief Financial Officer
Officer
|
10,000
+7.0%
0.48
USD 4,767
|
10,000
+7.0%
|
0.48
|
USD 4,767
|
|
|
2022-04-11 |
2022-04-08 |
B
Purchase
|
Giffin Brett A.
Chief Commercial Officer
Officer
|
10,600
+inf%
0.49
USD 5,183
|
10,600
+inf%
|
0.49
|
USD 5,183
|
|
|
2022-04-11 |
2022-04-07 |
B
Purchase
|
Gibbs Michael Terrence
General Counsel
Officer
|
10,000
+6.4%
0.49
USD 4,900
|
10,000
+6.4%
|
0.49
|
USD 4,900
|
|
|
2022-04-11 |
2022-04-07 |
B
Purchase
|
Sperzel John J III
Chairman, CEO, and President
Executive Director
|
30,000
+15.6%
0.50
USD 15,000
|
30,000
+15.6%
|
0.50
|
USD 15,000
|
|
|
2022-01-10 |
2022-01-06 |
PS
Planned sale
|
Ahuja Aparna
Chief Medical Officer
Officer
|
61,988
-36.5%
0.48
USD 29,754
|
61,988
-36.5%
|
0.48
|
USD 29,754
|
|
|
2021-03-25 |
2021-03-25 |
PS
Planned sale
|
Gibbs Michael Terrence
General Counsel
Officer
|
8,758
-10.7%
1.56
USD 13,662
|
8,758
-10.7%
|
1.56
|
USD 13,662
|
|
|
2021-03-18 |
2021-03-17 |
PS
Planned sale
|
Barclay Alec
Chief Operations Officer
Officer
|
12,494
-14.4%
1.86
USD 23,239
|
12,494
-14.4%
|
1.86
|
USD 23,239
|
|
|
2021-03-18 |
2021-03-17 |
PS
Planned sale
|
Pare Anthony
Chief Commercial Officer
Officer
|
9,620
-23.3%
1.84
USD 17,701
|
9,620
-23.3%
|
1.84
|
USD 17,701
|
|
|
2021-02-23 |
2021-02-23 |
PS
Planned sale
|
Sprague John M
Chief Financial Officer
Officer
|
5,250
-12.9%
2.04
USD 10,710
|
5,250
-12.9%
|
2.04
|
USD 10,710
|
|
|
2021-02-23 |
2021-02-23 |
PS
Planned sale
|
Gibbs Michael Terrence
General Counsel
Officer
|
7,280
-10.0%
2.06
USD 14,997
|
7,280
-10.0%
|
2.06
|
USD 14,997
|
|
|
2021-02-23 |
2021-02-23 |
PS
Planned sale
|
Barclay Alec
Chief Operations Officer
Officer
|
7,280
-10.0%
2.06
USD 14,997
|
7,280
-10.0%
|
2.06
|
USD 14,997
|
|
|
2020-03-03 |
2020-02-24 |
S
Sale
|
Sprague John M
Chief Financial Officer
Officer
|
4,166
-15.8%
0.82
USD 3,416
|
4,166
-15.8%
|
0.82
|
USD 3,416
|
|
|
2020-02-25 |
2020-02-24 |
PS
Planned sale
|
Lowery Thomas J.
Chief Scientific Officer
Officer
|
5,808
-7.8%
0.82
USD 4,763
|
5,808
-7.8%
|
0.82
|
USD 4,763
|
|
|
2020-02-25 |
2020-02-24 |
PS
Planned sale
|
Gibbs Michael Terrence
General Counsel
Officer
|
5,808
-8.7%
0.82
USD 4,763
|
5,808
-8.7%
|
0.82
|
USD 4,763
|
|
|
2020-02-25 |
2020-02-24 |
PS
Planned sale
|
Barclay Alec
SVP, Operations
Officer
|
5,808
-11.1%
0.82
USD 4,763
|
5,808
-11.1%
|
0.82
|
USD 4,763
|
|
|
2020-02-12 |
2020-02-11 |
PS
Planned sale
|
Lowery Thomas J.
Chief Scientific Officer
Officer
|
3,200
-4.7%
0.77
USD 2,464
|
3,200
-4.7%
|
0.77
|
USD 2,464
|
|
|
2020-02-12 |
2020-02-11 |
PS
Planned sale
|
Gibbs Michael Terrence
General Counsel
Officer
|
3,200
-5.4%
0.77
USD 2,464
|
3,200
-5.4%
|
0.77
|
USD 2,464
|
|
|
2020-02-05 |
2020-02-03 |
PS
Planned sale
|
Gibbs Michael Terrence
General Counsel
|
3,283
-5.7%
0.88
USD 2,889
|
3,283
-5.7%
|
0.88
|
USD 2,889
|
|
|
2020-02-05 |
2020-02-03 |
PS
Planned sale
|
McDonough John
|
23,754
-4.6%
0.88
USD 20,904
|
23,754
-4.6%
|
0.88
|
USD 20,904
|
|
|
2020-02-05 |
2020-02-03 |
PS
Planned sale
|
Lowery Thomas J.
Chief Scientific Officer
|
7,535
-10.8%
0.88
USD 6,631
|
7,535
-10.8%
|
0.88
|
USD 6,631
|
|
|
2020-01-27 |
2020-01-23 |
PS
Planned sale
|
McDonough John
|
57,417
-10.1%
1.15
USD 66,030
|
57,417
-10.1%
|
1.15
|
USD 66,030
|
|
|
2020-01-07 |
2020-01-03 |
PS
Planned sale
|
Elsbree David B
|
5,316
-5.5%
1.16
USD 6,167
|
5,316
-5.5%
|
1.16
|
USD 6,167
|
|
|
2019-09-13 |
2019-09-11 |
PS
Planned sale
|
Barclay Alec
SVP, Operations
|
4,210
-9.1%
2.92
USD 12,293
|
4,210
-9.1%
|
2.92
|
USD 12,293
|
|
|
2019-06-13 |
2019-06-11 |
PS
Planned sale
|
Cima Michael J.
|
3,240
-1.5%
1.43
USD 4,633
|
3,240
-1.5%
|
1.43
|
USD 4,633
|
|
|
2019-06-13 |
2019-06-11 |
PS
Planned sale
|
CUMMING JOHN W
|
3,420
-12.7%
1.43
USD 4,891
|
3,420
-12.7%
|
1.43
|
USD 4,891
|
|
|
2019-06-13 |
2019-06-11 |
PS
Planned sale
|
Lapidus Stanley
|
9,000
-14.5%
1.44
USD 12,960
|
9,000
-14.5%
|
1.44
|
USD 12,960
|
|
|
2019-06-13 |
2019-06-11 |
PS
Planned sale
|
Elsbree David B
|
3,600
-4.2%
1.44
USD 5,184
|
3,600
-4.2%
|
1.44
|
USD 5,184
|
|
|
2019-02-12 |
2019-02-11 |
PS
Planned sale
|
Gibbs Michael Terrence
General Counsel
Officer
|
3,005
-5.0%
3.36
USD 10,097
|
3,005
-5.0%
|
3.36
|
USD 10,097
|
|
|
2019-02-12 |
2019-02-11 |
PS
Planned sale
|
McDonough John
President & CEO
Executive Director
|
8,134
-1.8%
3.36
USD 27,330
|
8,134
-1.8%
|
3.36
|
USD 27,330
|
|
|
2019-02-12 |
2019-02-11 |
PS
Planned sale
|
Lowery Thomas J.
Chief Scientific Officer
Officer
|
3,005
-4.1%
3.36
USD 10,097
|
3,005
-4.1%
|
3.36
|
USD 10,097
|
|
|
2019-02-05 |
2019-02-01 |
S
Sale
|
Gibbs Michael Terrence
General Counsel
Officer
|
1,820
-3.2%
3.47
USD 6,315
|
1,820
-3.2%
|
3.47
|
USD 6,315
|
|
|
2019-02-05 |
2019-02-01 |
S
Sale
|
Lowery Thomas J.
Chief Scientific Officer
Officer
|
4,185
-5.9%
3.47
USD 14,522
|
4,185
-5.9%
|
3.47
|
USD 14,522
|
|
